Skip to Content

Stage 2 Menu Measures

Eligible professionals (EPs) must meet three of the six menu measures. As with the core measures, each measure has an objective that aligns with the dimensions of EHR use and functionality that the concept of meaningful use seeks to capture. The measure itself is a benchmark of achievement for the objective: for example, the measures often require that an EP use his EHR in the way specified by the objective for a specified percent of patients.

Unlike efforts toward Stage 1 Meaningful Use in 2012 and 2013, meaningful use cannot be achieved by selecting menu measures for which an EP can claim an exclusion if other menu measures exist for which he cannot claim an exclusion. An EP must achieve three measures unless he can claim an exclusion to four or more of the measures, in which case he must meet the remaining measures. For example, an EP who could claim exclusions to Menu Measures 1, 3, 4, and 6 would have to achieve measures 2 and 5 to be a meaningful user. An EP who could claim no exclusions may select which three measures to achieve.

Only one of these objectives, syndromic surveillance, has been revisited from Stage 1 Meaningful Use. As with Stage 1, the CMSspecification sheet for each measure is the best single source of information. Below are links to the Stage 2 objectives, with each individual webpage featuring:

  • the objective and measure as specified by CMS in the Stage 2 Final Rule
  • the CMS specification sheet
  • a comparison of the corresponding aspect of Stage 1 MU

More information on the measures will be available as Stage 2 approaches.  

1 Capability to submit electronic syndromic surveillance data to public health agencies, except where prohibited, and in accordance with applicable law and practice.
2  Record electronic notes in patient records.
3 Imaging results consisting of the image itself and any explanation or other accompanying information are accessible through Certified EHR Technology.
4 Record patient family health history as structured data.
5 Capability to identify and report cancer cases to a public health central cancer registry, except where prohibited, and in accordance with applicable law and practice.
6 Capability to identify and report specific cases to a specialized registry (other than a cancer registry), except where prohibited, and in accordance with applicable law and practice.

Contact Us

If you have any questions or concerns about meaningful use after viewing these webpages, please e-mail